Description of Imagenebio Inc's Business Segments

The Company operates as a single operating and reportable segment. The Chief Executive Officer, serving as the Chief Operating Decision Maker (CODM), reviews the Company's financial information on an aggregated basis to evaluate performance and allocate resources. Operating performance is assessed based on net loss reported in the consolidated statement of operations and comprehensive loss. The Company primarily derives license revenue in the United States from research and development collaborations and manages its business activities on a consolidated basis. All segment assets are located in the United States. The CODM receives detailed financial information, including license revenue, research and development expenses (clinical research and outside services, compensation and related costs, other research and development expenses, stock-based compensation), and general and administrative expenses (compensation and related costs, consulting and professional services, other general and administrative expenses, stock-based compensation) to support performance evaluation, resource allocation, and decision-making.

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Annual Report on Imagenebio Inc Divisions, Sales by Country

Twelve months ended 2025
IMA s Annual Revenue by Geography and Business Segments	Sales (in millions $)	% (of total Sales)
Total	0.80	100 %

Twelve months ended 2025
IMA s Annual Income by Country and Business Segments	Income (in millions $)	% (Profit Margin)
Total	-45.35	-

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments	% Y/Y Sales Growth	% Y/Y Income Growth

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.